These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 1758446)
21. Changes in the local cerebral metabolic rate for glucose in the MPTP primate model of Parkinson's disease. Schwartzman RJ; Alexander GM Adv Neurol; 1987; 45():171-3. PubMed ID: 3493624 [No Abstract] [Full Text] [Related]
22. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin]. Hirata Y; Nagatsu T Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683 [No Abstract] [Full Text] [Related]
23. Saccade responses to dopamine in human MPTP-induced parkinsonism. Hotson JR; Langston EB; Langston JW Ann Neurol; 1986 Oct; 20(4):456-63. PubMed ID: 3491578 [TBL] [Abstract][Full Text] [Related]
24. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism. Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441 [No Abstract] [Full Text] [Related]
25. Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia. Mitchell IJ; Luquin R; Boyce S; Clarke CE; Robertson RG; Sambrook MA; Crossman AR Mov Disord; 1990; 5(1):49-54. PubMed ID: 2296259 [TBL] [Abstract][Full Text] [Related]
36. Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Tetrud JW; Langston JW; Garbe PL; Ruttenber AJ Neurology; 1989 Nov; 39(11):1483-7. PubMed ID: 2812327 [TBL] [Abstract][Full Text] [Related]
37. Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey. Crossman AR; Peggs D; Boyce S; Luquin MR; Sambrook MA Neuropharmacology; 1989 Nov; 28(11):1271-3. PubMed ID: 2687716 [TBL] [Abstract][Full Text] [Related]
38. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake. Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267 [TBL] [Abstract][Full Text] [Related]
39. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus. Robertson RG; Graham WC; Sambrook MA; Crossman AR Brain Res; 1991 Nov; 563(1-2):278-80. PubMed ID: 1786541 [TBL] [Abstract][Full Text] [Related]
40. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease. Schwartzman RJ; Alexander GM Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]